At SempreFit Innovations, our commitment to advancing biotechnology extends into hands-on laboratory research. Alongside our data analytics and AI-driven platforms, we conduct bench-level investigations into exosomes, stem cells, peptides, and other regenerative biologic systems.
Our Focus Areas
- Exosome Analytics – Particle sizing and concentration using nanoparticle tracking analysis (NTA), identity confirmation via CD9/CD63/CD81 surface markers, and RNA/protein/lipid cargo profiling.
- Stem Cell Studies – Evaluating stem cell signaling pathways, exosome secretion, and regenerative potential across models of aging and disease.
- Peptide Research – Screening and profiling peptides for cell repair, metabolic regulation, neuroprotection, and anti-inflammatory actions.
- Immunomodulation Assays – In-vitro co-culture and molecular assays assessing immune response, inflammation resolution, and tissue repair.
Instrumentation & Capabilities
- Nanoparticle Tracking Analysis (NTA) for particle characterization
- Flow Cytometry for surface marker validation
- Molecular Assays (RNA sequencing, proteomics, lipidomics)
- Cell Culture Systems for in-vitro functional testing
- Quality Control Standards to evaluate purity, sterility, endotoxin levels, and reproducibility
Research Standards
All laboratory activities are conducted under Research Use Only (RUO) conditions. SempreFit Innovations maintains strict biosafety and quality control protocols to ensure that every batch of biologics is handled responsibly and assessed for functional impact.
All incoming exosome, stem cell, and peptide materials undergo rigorous QC including nanoparticle tracking, marker validation, purity checks, and sterility testing. Detailed QC standards available upon request.